198 related articles for article (PubMed ID: 35821246)
1. Difluoromethylornithine (DFMO) and AMXT 1501 inhibit capsule biosynthesis in pneumococci.
Ayoola MB; Shack LA; Lee JH; Lim J; Eoh H; Swiatlo E; Phanstiel O; Nanduri B
Sci Rep; 2022 Jul; 12(1):11804. PubMed ID: 35821246
[TBL] [Abstract][Full Text] [Related]
2. AMXT-1501, a novel polyamine transport inhibitor, synergizes with DFMO in inhibiting neuroblastoma cell proliferation by targeting both ornithine decarboxylase and polyamine transport.
Samal K; Zhao P; Kendzicky A; Yco LP; McClung H; Gerner E; Burns M; Bachmann AS; Sholler G
Int J Cancer; 2013 Sep; 133(6):1323-33. PubMed ID: 23457004
[TBL] [Abstract][Full Text] [Related]
3. Impact of Difluoromethylornithine and AMXT 1501 on Gene Expression and Capsule Regulation in
Ayoola MB; Shack LA; Phanstiel O; Nanduri B
Biomolecules; 2024 Feb; 14(2):. PubMed ID: 38397415
[No Abstract] [Full Text] [Related]
4. Glioma Metabolic Feedback In Situ: A First-In-Human Pharmacodynamic Trial of Difluoromethylornithine + AMXT-1501 Through High-Molecular Weight Microdialysis.
Riviere-Cazaux C; Neth BJ; Hoplin MD; Wessel B; Miska J; Kizilbash SH; Burns TC
Neurosurgery; 2023 Oct; 93(4):932-938. PubMed ID: 37246885
[TBL] [Abstract][Full Text] [Related]
5. Growth inhibition of pathogenic yeast isolates by alpha-difluoromethylornithine: an inhibition of ornithine decarboxylase.
Pfaller MA; Gerarden T; Riley J
Mycopathologia; 1987 Apr; 98(1):3-8. PubMed ID: 3108666
[TBL] [Abstract][Full Text] [Related]
6. Polyamine content of Pneumocystis carinii and response to the ornithine decarboxylase inhibitor DL-alpha-difluoromethylornithine.
Merali S; Clarkson AB
Antimicrob Agents Chemother; 1996 Apr; 40(4):973-8. PubMed ID: 8849262
[TBL] [Abstract][Full Text] [Related]
7. Difluoromethylornithine Combined with a Polyamine Transport Inhibitor Is Effective against Gemcitabine Resistant Pancreatic Cancer.
Gitto SB; Pandey V; Oyer JL; Copik AJ; Hogan FC; Phanstiel O; Altomare DA
Mol Pharm; 2018 Feb; 15(2):369-376. PubMed ID: 29299930
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of human ornithine decarboxylase activity by enantiomers of difluoromethylornithine.
Qu N; Ignatenko NA; Yamauchi P; Stringer DE; Levenson C; Shannon P; Perrin S; Gerner EW
Biochem J; 2003 Oct; 375(Pt 2):465-70. PubMed ID: 12859253
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of polyamine biosynthesis in Crithidia fasciculata by D,L-alpha-difluoromethylornithine and D,L-alpha-difluoromethylarginine.
Hunter KJ; Strobos CA; Fairlamb AH
Mol Biochem Parasitol; 1991 May; 46(1):35-43. PubMed ID: 1852175
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of growth of Giardia lamblia by difluoromethylornithine, a specific inhibitor of polyamine biosynthesis.
Gillin FD; Reiner DS; McCann PP
J Protozool; 1984 Feb; 31(1):161-3. PubMed ID: 6330350
[TBL] [Abstract][Full Text] [Related]
11. Polyamine depletion and growth inhibition in Candida albicans and Candida tropicalis by alpha-difluoromethylornithine and cyclohexylamine.
Pfaller MA; Riley J; Gerarden T
J Med Vet Mycol; 1988 Apr; 26(2):119-26. PubMed ID: 3138402
[TBL] [Abstract][Full Text] [Related]
12. Inhibitors of polyamine biosynthesis decrease the expression of the metalloproteases meprin alpha and MMP-7 in hormone-independent human breast cancer cells.
Matters GL; Manni A; Bond JS
Clin Exp Metastasis; 2005; 22(4):331-9. PubMed ID: 16170669
[TBL] [Abstract][Full Text] [Related]
13. Combination therapy with 2-difluoromethylornithine and a polyamine transport inhibitor against murine squamous cell carcinoma.
Chen Y; Weeks RS; Burns MR; Boorman DW; Klein-Szanto A; O'Brien TG
Int J Cancer; 2006 May; 118(9):2344-9. PubMed ID: 16331620
[TBL] [Abstract][Full Text] [Related]
14. Dual targeting of polyamine synthesis and uptake in diffuse intrinsic pontine gliomas.
Khan A; Gamble LD; Upton DH; Ung C; Yu DMT; Ehteda A; Pandher R; Mayoh C; Hébert S; Jabado N; Kleinman CL; Burns MR; Norris MD; Haber M; Tsoli M; Ziegler DS
Nat Commun; 2021 Feb; 12(1):971. PubMed ID: 33579942
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor: modulator of murine embryonic palate mesenchymal cell proliferation, polyamine biosynthesis, and polyamine transport.
Gawel-Thompson KJ; Greene RM
J Cell Physiol; 1989 Aug; 140(2):359-70. PubMed ID: 2501317
[TBL] [Abstract][Full Text] [Related]
16. Biochemical and morphological effects of polyamine biosynthesis inhibitors on Trichophyton and Microsporum.
Gruhn CM; Boyle SM
J Med Vet Mycol; 1991; 29(2):63-72. PubMed ID: 1880681
[TBL] [Abstract][Full Text] [Related]
17. Revival of 2-(difluoromethyl)ornithine (DFMO), an inhibitor of polyamine biosynthesis, as a cancer chemopreventive agent.
Raul F
Biochem Soc Trans; 2007 Apr; 35(Pt 2):353-5. PubMed ID: 17371277
[TBL] [Abstract][Full Text] [Related]
18. A Phase I Trial of DFMO Targeting Polyamine Addiction in Patients with Relapsed/Refractory Neuroblastoma.
Saulnier Sholler GL; Gerner EW; Bergendahl G; MacArthur RB; VanderWerff A; Ashikaga T; Bond JP; Ferguson W; Roberts W; Wada RK; Eslin D; Kraveka JM; Kaplan J; Mitchell D; Parikh NS; Neville K; Sender L; Higgins T; Kawakita M; Hiramatsu K; Moriya SS; Bachmann AS
PLoS One; 2015; 10(5):e0127246. PubMed ID: 26018967
[TBL] [Abstract][Full Text] [Related]
19. Characterising the Response of Human Breast Cancer Cells to Polyamine Modulation.
Akinyele O; Wallace HM
Biomolecules; 2021 May; 11(5):. PubMed ID: 34067619
[TBL] [Abstract][Full Text] [Related]
20. Alpha-difluoromethylornithine, an inhibitor of polyamine biosynthesis, augments cyclosporin A inhibition of cytolytic T lymphocyte induction.
Bowlin TL; Rosenberger AL; McKown BJ
Clin Exp Immunol; 1989 Jul; 77(1):151-6. PubMed ID: 2504519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]